These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of nicotinic receptor-mediated responses in bovine chromaffin cells by diltiazem. Gandía L; Villarroya M; Sala F; Reig JA; Viniegra S; Quintanar JL; García AG; Gutiérrez LM Br J Pharmacol; 1996 Jul; 118(5):1301-7. PubMed ID: 8818357 [TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y secretion from bovine chromaffin cells inhibits cyclic AMP accumulation. Zheng J; Zhou G; Hexum TD Life Sci; 2000 Jun; 67(6):617-25. PubMed ID: 12659167 [TBL] [Abstract][Full Text] [Related]
4. Blockade of nicotinic receptors of bovine adrenal chromaffin cells by nanomolar concentrations of atropine. González-Rubio JM; García de Diego AM; Egea J; Olivares R; Rojo J; Gandía L; García AG; Hernández-Guijo JM Eur J Pharmacol; 2006 Mar; 535(1-3):13-24. PubMed ID: 16530180 [TBL] [Abstract][Full Text] [Related]
5. Noncompetitive inhibition by camphor of nicotinic acetylcholine receptors. Park TJ; Seo HK; Kang BJ; Kim KT Biochem Pharmacol; 2001 Apr; 61(7):787-93. PubMed ID: 11274963 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226. Lundberg JM; Modin A Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732 [TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process. Zheng J; Zhang P; Hexum TD Mol Pharmacol; 1997 Dec; 52(6):1027-33. PubMed ID: 9415712 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of nicotinic receptor-mediated catecholamine secretion by Dryobalanops aromatica in bovine adrenal chromaffin cells. Oh KS; Park TJ; Choi BH; Lee DK; Lee TK; Kim KT Pharmacol Res; 2000 Dec; 42(6):559-64. PubMed ID: 11058409 [TBL] [Abstract][Full Text] [Related]
9. Amphetamine enhances Ca2+ entry and catecholamine release via nicotinic receptor activation in bovine adrenal chromaffin cells. Liu PS; Liaw CT; Lin MK; Shin SH; Kao LS; Lin LF Eur J Pharmacol; 2003 Jan; 460(1):9-17. PubMed ID: 12535854 [TBL] [Abstract][Full Text] [Related]
10. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters. Mahapatra NR; Mahata M; Mahata SK; O'Connor DT J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252 [TBL] [Abstract][Full Text] [Related]
11. Phytoestrogen cimicifugoside-mediated inhibition of catecholamine secretion by blocking nicotinic acetylcholine receptor in bovine adrenal chromaffin cells. Woo KC; Park YS; Jun DJ; Lim JO; Baek WY; Suh BS; Kim KT J Pharmacol Exp Ther; 2004 May; 309(2):641-9. PubMed ID: 14757852 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435. Malmstrom RE; Lundberg JM Eur J Pharmacol; 1995 Dec; 294(2-3):661-8. PubMed ID: 8750731 [TBL] [Abstract][Full Text] [Related]
13. Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries. Yang XP; Chiba S Br J Pharmacol; 2000 Aug; 130(7):1699-705. PubMed ID: 10928977 [TBL] [Abstract][Full Text] [Related]
14. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226. Gicquiaux H; Tschöpl M; Doods HN; Bucher B Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226. Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541 [TBL] [Abstract][Full Text] [Related]